US4940588A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Controlled release powder and process for its preparation
Assignee: Perrigo Pharma International DAC
•
Filing: 1988-03-17
•
Granted: 1990-07-10
•
Expires: 2008-03-17
Abstract
Abstract A controlled release powder containing discrete micro-particles for use in edible, pharmaceutical and other controlled release compositions is disclosed. The micro-particles have an average size in the range of from 0.1 to 125 mu m. Each of the micro-particles is in the form of a micromatrix of an active ingredient uniformly distributed in at least one non-toxic polymer. The micro-particles have a predetermined release of active ingredient when the dissolution rate thereof is measured according to the Paddle Method of U.S. Pharmacopoeia XX at 37 DEG C. and 75 r.p.m.
Inventors
- 👤 Randall T. Sparks
- 👤 Edward J. Geoghegan
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 12:40
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0087; A61K9/0095; A23; A23G; A23G4/00; A23G4/18; A23G4/20; A61K9/0012; A61K9/0053; A61K9/0056; A61K9/14; A61K9/16; A61K9/1605; A61K9/1629; A61K9/1635; A61K9/1652; A61K9/1682; A61K9/1694; A61K9/48; A61K9/50; A61K9/51; A61K9/5107; A61K9/513; A61K9/5138; A61K9/5161; A61P; A61P11/00; A61P11/08; Y; Y10; Y10T; Y10T428/00; Y10T428/29; Y10T428/2982; Y10T428/2989
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
119 words
A controlled release taste-masked powder containing discrete micro-particles for use in edible, pharmaceutical and other controlled release compositions, said powder comprising particles containing theophylline as an active ingredient in intimate admixture with two polymers, cellulose acetate butyrate and polyvinylpyrrolidone, in an amount effective to provide a predetermined and controlled release of said active ingredient, each of said particles being in the form of a micromatrix with the active ingredient uniformly distributed throughout the matrix, but not entirely coated by the polymers, said particles having an average size of from 0.1 to 125 μm, being unlikely to be significantly degraded or ground by any chewing action, and wherein said predetermined release of active ingredient is suitable for twice daily administration.
Claim 2
Dependent Claim
119 words
A controlled release taste-masked powder containing discrete micro-particles for use in edible, pharmaceutical and other controlled release compositions, said powder comprising particles containing theophylline as an active ingredient in intimate admixture with two polymers, cellulose acetate butyrate and polyvinylpyrrolidone, in an amount effective to provide a predetermined and controlled release of said active ingredient, each of said particles being in the form of a micromatrix with the active ingredient uniformly distributed throughout the matrix, but not entirely coated by the polymers, said particles having an average size of from 0.1 to 125 μm, being unlikely to be significantly degraded or ground by any chewing action, and wherein said predetermined release of active ingredient is suitable for twice daily administration.
Claim 3
Dependent Claim
213 words
A controlled release taste-masked powder containing discrete micro-particles for use in edible, pharmaceutical and other controlled release compositions, said powder comprising particles containing theophylline as an active ingredient in intimate admixture with at least two polymers, at least one of which is soluble and at least one of which is water insoluble, in an amount effective to provide a predetermined and controlled release of said active ingredient, each of said particles being in the form of a micromatrix with the active ingredient uniformly distributed throughout the matrix, but not entirely coated by the polymers, said particles having an average size of from 0.1 to 125 μm, being unlikely to be significantly degraded or ground by any chewing action, and wherein said predetermined release of active ingredient is suitable for twice daily administration, wherein said soluble polymer(s) is (are) selected from the group consisting of: polyvinyl alcohols, water soluble alkyl celluloses, hydroxyalkyl celluloses, water soluble cellulose esters, polyalkylene glycols, polyvinylpyrrolidone, and polymers thereof, and said water insoluble polymer(s) is (are) selected from the group consisting of water insoluble alkyl celluloses, water insoluble cellulose esters, nitro celluloses, polymers of acrylic and methacrylic acids and esters thereof, polyamide, polycarbonates, polyalkylenes, polyalkyline oxides, polyalkylene terephthalates, polyvinyl ethers, polyvinyl esters, polyvinyl halides, polyglycolides, polysiloxanes, polyurethanes, and co-polymers thereof.
Claim 4
Dependent Claim
213 words
A controlled release taste-masked powder containing discrete micro-particles for use in edible, pharmaceutical and other controlled release compositions, said powder comprising particles containing theophylline as an active ingredient in intimate admixture with at least two polymers, at least one of which is soluble and at least one of which is water insoluble, in an amount effective to provide a predetermined and controlled release of said active ingredient, each of said particles being in the form of a micromatrix with the active ingredient uniformly distributed throughout the matrix, but not entirely coated by the polymers, said particles having an average size of from 0.1 to 125 μm, being unlikely to be significantly degraded or ground by any chewing action, and wherein said predetermined release of active ingredient is suitable for twice daily administration, wherein said soluble polymer(s) is (are) selected from the group consisting of: polyvinyl alcohols, water soluble alkyl celluloses, hydroxyalkyl celluloses, water soluble cellulose esters, polyalkylene glycols, polyvinylpyrrolidone, and polymers thereof, and said water insoluble polymer(s) is (are) selected from the group consisting of water insoluble alkyl celluloses, water insoluble cellulose esters, nitro celluloses, polymers of acrylic and methacrylic acids and esters thereof, polyamide, polycarbonates, polyalkylenes, polyalkyline oxides, polyalkylene terephthalates, polyvinyl ethers, polyvinyl esters, polyvinyl halides, polyglycolides, polysiloxanes, polyurethanes, and co-polymers thereof.
Claim 5
Dependent Claim
17 words
A pharmaceutical composition containing a pharmaceutically effective amount of a controlled release powder according to claim 2.
Claim 6
Dependent Claim
31 words
A pharmaceutical composition containing a pharmaceutically effective amount of a controlled release powder according to claim 2 and which is in the form of tablets, capsules, suppositories, implants, or ocular inserts.
Claim 7
Dependent Claim
17 words
A pharmaceutical composition according to claim 3 which is the form of chewable tablets or melt tablets.
Claim 8
Dependent Claim
29 words
A pharmaceutical composition containing a pharmaceutically effective amount of a controlled release powder according to claim 2 and which is in the form of a liquid for oral administration.
Claim 9
Dependent Claim
23 words
A pharmaceutical composition according to claim 6 which is in the form of drops, a suspension, a syrup, or an infusion or solution.
References Cited (Backward Citations)
CA873815A
Cited
BE678097A
Cited
US2928770A
Cited
US3115441A
Cited
US3432593A
Cited
US3341416A
Cited
GB1056259A
Cited
US3594326A
Cited
US3460972A
Cited
US3488418A
Cited
GB1205769A
Cited
US3520970A
Cited
US3657144A
Cited
US3594470A
Cited
US3732172A
Cited
US3576759A
Cited
US3639306A
Cited
US3539465A
Cited
US3634586A
Cited
US3691090A
Cited
US3567650A
Cited
US3642978A
Cited
US3887699A
Cited
GB1287431A
Cited
US3703576A
Cited
US3629392A
Cited
US3780195A
Cited
US3714065A
Cited
US3737337A
Cited
US3835221A
Cited
US3959457A
Cited
US3775537A
Cited
US3728445A
Cited
US3725556A
Cited
US3821422A
Cited
US3859228A
Cited
US3909444A
Cited
US3943063A
Cited
US3891570A
Cited
CA1025359A
Cited
US4016254A
Cited
US3951851A
Cited
US3860733A
Cited
DE2237503A1
Cited
JPS4962623A
Cited
JPS4993522A
Cited
US3954959A
Cited
US3922338A
Cited
US4083949A
Cited
JPS5094112A
Cited
GB1478947A
Cited
US4118336A
Cited
JPS5158401A
Cited
US4123381A
Cited
US4011312A
Cited
US4221862A
Cited
US4324683A
Cited
US4101651A
Cited
GB1569036A
Cited
US4254100A
Cited
WO1978000011A1
Cited
EP0002574A1
Cited
US4223006A
Cited
GB2017624A
Cited
US4182778A
Cited
US4230687A
Cited
US4489055A
Cited
US4205060A
Cited
US4368197A
Cited
US4201822A
Cited
US4293539A
Cited
GB2059764A
Cited
JPS56152739A
Cited
US4384975A
Cited
US4321253A
Cited
CA1142810A
Cited
US4389330A
Cited
WO1983000284A1
Cited
US4587118A
Cited
US4452821A
Cited
EP0094513A2
Cited
US4415547A
Cited
US4690682A
Cited
US4789516A
Cited
US4497832A
Cited
US4605550A
Cited
US4632822A
Cited
US4647450A
Cited
US4647459A
Cited
GB2147501A
Cited
US4749575A
Cited
US4818542A
Cited
US4678516A
Cited
US4690825A
Cited
US4800087A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1993-07-09 | 1994-01-08 | 1994-07-10 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1997-07-09 | 1998-01-08 | 1998-07-10 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2001-07-09 | 2002-01-08 | 2002-07-10 | $7700.00 | Window Closed / Lapsed |